Lasa Supergenerics submits standalone financial results

29 Nov 2018 Evaluate

With reference to the observation received from Bombay Stock Exchange dated November 28, 2018 for the in principal approval for Right Issue, Lasa Supergenerics has submitted the Signed Standalone Financial Results for the quarter and year ended March 31, 2018 along with auditors report.

The above information is a part of company’s filings submitted to BSE.

Lasa Supergenerics Share Price

9.90 -0.10 (-1.00%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×